Trial
NCT04811404
A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Bipolar Disorder
Intervention
Ethyl Eicosapentaenoic Acid
Why stopped
Reassessment of rationale for study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-14